Lab · USP 795/797Formulation development
New preparations taken from idea to a validated master formula.
- Sterile & non-sterile formulas
- Stability studies & BUD strategy
- Peptide, GLP-1 & hormone programs
MK Pharmacy Advisory helps 503A pharmacies, 503B outsourcing facilities, manufacturers and telehealth companies develop products, build facilities, get licensed and scale up. Our advice comes from a pharmacist who has built and run these facilities himself.
USP 795Non-sterile compoundingUSP 797Sterile compoundingUSP 800Hazardous drug handling21 CFR 211cGMP for 503B facilitiesISO 14644Cleanroom classificationHire us for one piece, such as a USP 797 audit, or for the whole project, from empty shell to commercial-scale production.
Lab · USP 795/797New preparations taken from idea to a validated master formula.
Production · 503BMoving a product from small batches to steady commercial volume.
Cleanroom · ISO 5/7/8Cleanrooms and labs planned to pass before the first wall goes up.
Permits · 50 statesPharmacy permits and registrations in every state you ship to.
Audit · USP 797/800Independent audits and written programs your staff can follow.
Systems · ERPSystems that connect intake, compounding, QA and shipping.
Fulfillment · RxPharmacy back ends for virtual-care and wellness platforms.
Cold chain · 2–8 °CGetting finished product to patients and clinics nationwide.
Build · Buy · SellFull builds, acquisitions and sales handled by one team.

Most consultants have inspected pharmacies. We have built, licensed and run them. That changes the advice: fewer theoretical findings, more fixes your team can carry out next week.
Every photo here comes from a facility Amer has built, scaled, operated or owned. None of it is stock imagery. This is the work behind the advice.











Planning a build of your own? Walk through it with us →
| Standard | Covers | Applies to |
|---|---|---|
USP <795> | Non-sterile compounding: facilities, components, BUDs, documentation | 503A pharmacies |
USP <797> | Sterile compounding: garbing, aseptic technique, environmental monitoring, BUDs | 503A pharmacies |
USP <800> | Hazardous drugs: containment, negative-pressure rooms, PPE, deactivation | 503A & 503B |
21 CFR 210/211 | Current good manufacturing practice, batch records, quality unit | 503B outsourcing facilities |
ISO 14644-1 | Cleanroom particle classification and certification | Any sterile operation |
F.S. 465 · 64B16 | Florida pharmacy law and Board of Pharmacy rules | Florida-permitted pharmacies |
Every engagement ends with documents and systems your team keeps using after we leave.
Gap reportFindings ranked by inspection risk, each with a fix, an owner and a target date.
SOP libraryFacility, personnel, compounding, cleaning and QA procedures tailored to your operation.
Master formulation recordsFormulas, compounding records and BUD justifications for each preparation.
EM programViable and non-viable sampling plans, maps, action levels and trending templates.
Training kitGarbing, aseptic technique and hazardous drug competency packages with sign-off records.
Licensing packetCompleted applications, supporting policies and inspection checklists for each state.
Site visit or document review, then a written gap report ranked by risk.
Scope, budget and timeline for design, licensing and quality systems.
We work alongside your contractor, certifier and staff through construction and validation.
Mock inspection, final corrections and support on inspection day.
Quick answers on a regulation, a floor plan or a vendor quote. Ideal before you sign a lease or a contract.
A defined outcome, such as a USP 797 audit, a state license or a full cleanroom build, with a set fee and timeline.
Continuing oversight for pharmacies that want an experienced pharmacist reviewing their program every month.

Led design, cleanroom construction, quality systems and FDA registration for a sterile 503B outsourcing facility, working directly with the cleanroom contractor through certification.

Co-owned a 503A compounding pharmacy and was involved in its compounding operations, compliance and growth. That ownership experience shapes how we advise other pharmacy owners.

Founded a telehealth platform and built both sides of it: the technology and the pharmacy fulfillment model, from prescriber workflow to patient shipping.
From a single pharmacist opening a first location to investors evaluating an acquisition.

Amer is a pharmacist licensed in 20 states with a background in engineering and technology. He has served as Pharmacist-in-Charge, built a 503B outsourcing facility in Palm Harbor from the ground up, and previously co-owned a 503A compounding pharmacy. He is also the founder of a GLP-1 and peptide telehealth platform, where he leads both the technology and the pharmacy operations. MK Pharmacy Advisory brings that mix of pharmacy, engineering and tech to every client.
Yes. We're based in the Tampa Bay area and support clients nationwide, including non-resident licensing in other states.
It depends on whether you'll dispense patient-specific prescriptions or supply office-use stock to clinics and hospitals. We walk through volume, product list, capital and regulatory load with you before you commit.
Most 503A cleanroom projects run several months from design to certification. Permitting and Board inspection add time, so we plan those in parallel.
Yes. A gap audit or mock inspection gives you a ranked list of findings and fixes before a regulator finds them.
Yes. We're glad to sign an NDA before reviewing your plans or documents.
Yes. A focused mock inspection and corrective plan can be completed in a few weeks. The sooner we start, the more findings you can close before the visit.
Yes. We review drawings, attend site meetings and sign off on punch lists alongside the team you already have.
Yes. We help you investigate root causes, write corrective actions and draft a response within FDA's 15-business-day window.
Yes. Our due diligence covers licenses, compliance history, facility condition and operational risk before you close.
A pharmacist reviews every inquiry. Consultations are confidential.